QBJ

Integrated Continuous Glucose Monitoring System, Factory Calibrated

Product code
QBJ
Device name
Integrated Continuous Glucose Monitoring System, Factory Calibrated
Device class
Class 2
21 CFR
21 CFR 862.1355
Medical specialty
Clinical Chemistry
Marketing pathway
510(K)
510(k) clearances (last 3 years)
7
Summaries archived here
6 (direct download)
510(k) clearances (all years, FDA)
18 (all years; only the last 3 years are listed here)

FDA classification definition

An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with these digitally connected medical devices for the purpose of managing a disease or condition related to glycemic control.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (7)

Last three years. Most recent: 2026-06-08.

NumberDecision dateApplicantDevice nameSummary
K2614022026-06-08Dexcom, Inc.Dexcom G7 Continuous Glucose Monitoring System;Dexco…PDF
K2537372026-02-03Dexcom, Inc.Dexcom G7 Continuous Glucose Monitoring (CGM) System…PDF
K2537102025-12-17Dexcom, Inc.Dexcom G7 Continuous Glucose Monitoring (CGM) System…PDF
K2432142025-04-09Dexcom, Inc.Dexcom G7 15 Day Continuous Glucose Monitoring Syste…PDF
K2409022024-04-23Dexcom, Inc.Dexcom G7 Continuous Glucose Monitoring SystemPDF
K2335372024-04-23Abbott Diabetes Care, Inc.FreeStyle Libre 3 Continuous Glucose Monitoring Syst…FDA
K2341332024-02-26Dexcom, Inc.Dexcom G7 Continuous Glucose Monitoring SystemPDF

6 summaries are archived here for direct download.

Official FDA classification page: QBJ
Classification and pathway per current FDA publications. Data from openFDA (CC0).